Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep350 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Hepatopathy of Mauriac síndrome: a case report

Tirado Antonio Moreno , Lazaro Paloma Gonzalez , Montero Benitez Maria Zhao , Torrecilla Pedro Jimenez , Val Zaballos Florentino Del , Meneses Amparo Lomas

We report the case of a 34-year-old woman with a personal history of type 1 diabetes mellitus (DM1) since she was 9 years old. Very poor chronic metabolic control stands out despite multiple insulin schemes with multiple complications: nephropathy, retinopathy and peripheral neuropathy. She was admitted to the hospitalization floor due to diabetic ketoacidosis. At admission Hba1c of 15.3%. During admission after treatment with IV insulin, improvement in glycemic control. Nine ...

ea0091p17 | Poster Presentations | SFEEU2023

47 XYY Syndrome; compared to XXY; do both ‘Y’ and Thyroxine differ?

Solomon Andrew , Haddad Aiman , Saifee Tabish

Case history: We present a 61-year-old male with a background history of 47 XYY syndrome who was referred to the endocrine outpatient service with abnormal thyroid function tests. He has mild learning disabilities, asthma, action tremor, erectile dysfunction, and type 2 diabetes. He was tall in stature with obvious clinodactyly. He had been evaluated for his tremor by our Neurology colleagues. Investigations: His blood tests results were as follow- TSH 5...

ea0069p69 | Poster Presentations | SFENCC2020

Isolated Langerhans cell histiocytosis in hypothalamic–pituitary region

Khan Amber , Gnanalingham K , Kearney Tara

Case history: We present a rare case of Langerhans cell histiocytosis (LCH) of pituitary stalk and hypothalamus in a 40 year old lady. She presented with 9 weeks history of a sudden onset of polyuria and polydipsia. She had extreme thirst even during night which led to significant nocturia and tiredness. She denied headache, blurring of vision, galactorrhoea or menstrual irregularity. She had no significant past medical history and was not on any medications. Physical examinat...

ea0063oc5.3 | Adrenal 1 | ECE2019

SF3B1 as novel target for the treatment of multiple endocrine-related cancers

Jimenez-Vacas Juan M , Lopez-Canovas Juan L , Vazquez-Borrego Mari C , Pedraza-Arevalo Sergio , del Rio-Moreno Mercedes , Herrero-Aguayo Vicente , Saez-Martinez Prudencio , Montero-Hidalgo Antonio J , Encinas Ricardo Blazquez , Lara-Lopez Araceli , Perez-Gomez Jesus M , Gomez-Gomez Enrique , Herrera-Martinez Aura , Gadelha Monica R , Castano Justo P , Gahete Manuel D , Luque Raul M

The intrinsic heterogeneity of endocrine-related cancers (ERCs) hampers the identification and development of global and effective therapeutic treatments for these pathologies. However, the dysregulation of the splicing process has been postulated as a new common hallmark shared by most cancer types, since it is associated with the appearance of splicing variants with oncogenic potential (e.g. CD44v6, BCL-Xs, AR-v7, SST5TMD4, In1-ghrelin...

ea0063gp6 | Adrenal and Neuroendocrine - Tumour | ECE2019

Cellular modelling of SDH-associated pathomechanism of pheochromocytomas and paragangliomas

Sarkadi Balazs , Meszaros Katalin , Krencz Ildiko , Zakarias Sara , Nemeth Kinga , Barja Gabor , Sebestyen Anna , Papay Judit , Borka Katalin , Hujber Zoltan , Toth Miklos , Igaz Peter , Chinopoulos Christos , Patocs Attila

Introduction: The capability of cancer to accommodate to special metabolic circumstances is a hallmark of it’s existence. Pheochromocytoma/paragangliomas (Pheo/PGL) are rare neuroendocrine tumors with strong and specific metabolic phenotype due to mutations of genes encoding succinate dehydrogenase (SDH) subunits. In this study our aim was to evaluate the expression of glutaminase-1 in hereditary Pheo/PGL tissues and to inhibit SDH activity via pharmacological treatments ...

ea0063gp161 | Cushing's | ECE2019

Ubiquitin-specific protease 8 (USP8) potentiates glucocorticoid receptor activity in corticotroph tumour cells

Perez-Rivas Luis , Ciato Denis , Colon-Bolea Paula , Reincke Martin , Theodoropoulou Marily

Cushing’s disease tumours bear activating mutations in the ubiquitin-specific-protease 8 gene (USP8) gene in 40-60% of cases. We have previously observed that patients with USP8 mutant tumours have smaller tumour size and show a better response to high dose (8mg) dexamethasone stimulation test compared to those with wild type USP8 (1). The aim of this study was to define the role of USP8 on glucocorticoid receptor (GR) in corticotroph tumour cells. We did experim...

ea0063p822 | Adrenal and Neuroendocrine Tumours 3 | ECE2019

Melasma as a sign of Addison’s disease: case report

Maghfour Soukaina , Abed Yosra Hasni El , Gammoudi Rima , Boussofara Lobna , Kahla Marwen Ben , Aouinallah Amina , Mokni Sana , Ghariani Najet , Belajouza Colandane , Denguezli Mohamed

Introduction: Addison’s disease was first described in 1855 by Thomas Addison as a result of adrenal insufficiency. It is most common in females aged 30–50 years. Symptoms are often non specific.Weakness and weight loss are universal features of Addison’s disease. It can present to a dermatologist in different ways. We present a case of a young female who reported to dermatology outdoor with a typical melasma-like eruption over her face.Ca...

ea0041d4.2 | Are we ready for pharmacological therapy of obesity? | ECE2016

Should we treat subclinical Cushing’s syndrome?

Stewart Paul M

The term subclinical Cushing syndrome arose at the turn of the millennium with the description of large Italian study of adrenal incidentalomas. Of 1096 patients from 26 centres, 9.2% had ‘subclinical Cushing’s’ (JCEM, 2000; 85:637-644). Since then over 300 publications have detailed this newly discovered endocrine diagnosis, and herein lies the main issue. The definition of Cushing’s syndrome is not in doubt – a ‘constellation of symptoms and sig...

ea0040l1 | Advances in molecular pathogenesis of thyroid cancer | ESEBEC2016

Advances in molecular pathogenesis of thyroid cancer

Santisteban Pilar

The presence of differentiated follicular thyroid cells in thyroid cancer is critical for the antitumor response to radioactive iodide treatment, and loss of the differentiated phenotype is a key hallmark of iodide-refractory metastatic disease. Thus, one of the objective of our laboratory is to study the signals and molecular mechanisms involved in thyroid differentiation in cancer. Among genes responsible of thyroid differentiated phenotype are the transcription factor PAX8 ...

ea0035p690 | Male reproduction | ECE2014

The variant FSHB −211G>T attenuates serum FSH levels in the supraphysiological gonadotropin setting of Klinefelter syndrome

Gromoll Joerg , Busch Alexander , Zitzmann Michael , Kliesch Sabine , Tuettelmann Frank

Background: Klinefelter syndrome (KS) is the most frequent genetic cause of male infertility. Individuals share the endocrine hallmark of hypergonadotropic hypogonadism, displaying high gonadotropin levels due to deficient testicular function. A single-nucleotide polymorphism (SNP) located within the FSHB promoter region (−211G>T, rs10835638) was recently shown to be associated with reduced serum FSH levels and other reproductive parameters in men. The objec...